Advanced Micro Devices Rises 18% in a Month: Buy or Hold the Stock?

Advanced Micro Devices (AMD) shares have recently surged, despite a Q2 2025 performance impacted by U.S. export controls on MI308 sales to China, which led to an $800 million inventory write-down and margin compression. The company projects robust Q3 revenue growth of 28% year-over-year, driven by its expanding AI portfolio, including new Instinct MI350 GPUs and EPYC processors, and strong hyperscaler partnerships. However, AMD faces stiff competition from NVIDIA in the AI chip market and its stock is currently considered overvalued, tempering the near-term outlook.

Analysis

Advanced Micro Devices (AMD) presents a conflicting profile of near-term operational headwinds against a strong long-term growth narrative in AI. While the stock has surged 17.8% in the past month, outperforming NVIDIA, it also dropped 1.1% following its Q2 2025 earnings report. The quarterly results were materially impacted by U.S. export controls on MI308 sales to China, necessitating an $800 million inventory write-down and causing significant margin compression; gross margin fell to 43% from 53% year-over-year, and operating margin declined to 12% from 22%. Despite this, forward guidance for Q3 2025 is robust, with projected revenue of approximately $8.7 billion, representing 28% year-over-year growth, and a recovery in non-GAAP gross margin to 54%. This optimism is fueled by the ramp-up of its new Instinct MI350 GPUs and strong EPYC processor demand, underscored by major deployments with partners like Meta, Oracle, and Microsoft. However, AMD faces intense competition from an accelerating NVIDIA, and its valuation appears stretched, trading at a forward 12-month Price/Sales ratio of 7.71X, more than double the industry average of 3.72X.

Key Decisions for Investors

• Investors should closely monitor the Q3 earnings report for confirmation of the guided 28% year-over-year revenue growth and the rebound in non-GAAP gross margin to 54%, as failure to meet these targets could pressure the stock's high valuation.
• Given the stock's premium valuation and stiff competition from NVIDIA, consider waiting for a potential pullback or more concrete evidence of market share gains in the AI accelerator space before establishing or adding to a position.
• Focus on the adoption rate and performance benchmarks of the new MI350 GPU series and EPYC Turin CPUs with key hyperscalers like Meta and Oracle, as these are the primary catalysts that could justify the company's growth outlook and current share price.